Cargando…
Current and evolving treatment strategies in adult immune thrombocytopenia
Immune thrombocytopenia (ITP) is an acquired autoimmune phenomenon resulting in low platelet count and increased bleeding risk. Goals of upfront management include prompt control of severe bleeding—which is rare—as well as induction and maintenance of a hemostatic platelet count. Thus, optimal manag...
Autores principales: | Bohn, Jan-Paul, Steurer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132792/ https://www.ncbi.nlm.nih.gov/pubmed/30220932 http://dx.doi.org/10.1007/s12254-018-0428-7 |
Ejemplares similares
-
Evolving treatment modalities for immune thrombocytopenia in adults
por: Khadka, Sushmita, et al.
Publicado: (2021) -
Agony of choice—selecting chronic lymphocytic leukemia treatment in 2022
por: Bohn, Jan-Paul
Publicado: (2022) -
Current Management of Primary Immune Thrombocytopenia
por: Provan, Drew, et al.
Publicado: (2015) -
Sunitinib Induced Immune Thrombocytopenia
por: Shekarriz, Ramin, et al.
Publicado: (2015) -
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine
por: Bohn, Jan-Paul, et al.
Publicado: (2019)